Phoenix Solutions AS completes its Series B financing.

The Board of Directors of Phoenix Solutions is pleased to announce that the company has completed a series B financing led by current shareholder, Investinor AS and an expanded group of healthcare angel investors. CEO Per Sontum.

We are very pleased to announce this second round of financing which, including the recently awarded BIA program from RCN, will give us the ability to meet a key developmental milestone; start of a clinical phase I/IIa program for treatment of non-resectable pancreatic cancer in 2018.